In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors.
- InMed does not grow cannabis. We biosynthesize the compounds in a lab.
- InMed products do not contain THC.
- InMed products are applied topically.
In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors.
Dr. Shane Johnson, GM of BayMedica, InMed’s subsidiary, answers these questions: What is the minimum GMP standard that consumers should expect? What quality controls should
Dr. Shane Johnson, GM of BayMedica, InMed’s subsidiary, answers these questions: What is the role of the endocannabinoid system? How do cannabinoids interact with the
Dr. Shane Johnson, GM of BayMedica, InMed’s subsidiary, answers these questions: What are illegal synthetic cannabinoids? How are illegal synthetic cannabinoids different from bioidentical synthesized
© Copyright 2023 InMed Pharmaceuticals Inc.
"*" indicates required fields